<DOC>
	<DOCNO>NCT00863304</DOCNO>
	<brief_summary>Test efficacy safety 2 dos tanezumab compare naproxen placebo patient osteoarthritis</brief_summary>
	<brief_title>Tanezumab Osteoarthritis Hip Knee ( 2 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Osteoarthritis hip knee accord KellgrenLawrence xray grade 2 pregnancy intent become pregnant BMI great 39 severe pain , significant cardiac , neurological psychiatric disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth factor OA pain arthritis</keyword>
</DOC>